rs587777357
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_178014.4(TUBB):c.1201G>A(p.Glu401Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_178014.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Multiple benign circumferential skin creases on limbs 1 Pathogenic:2
- -
The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.77; 3Cnet: 0.93). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000127191). The variant has been previously reported as de novo in a similarly affected individual (PMID: 23246003). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
Complex cortical dysplasia with other brain malformations 6 Pathogenic:2
- -
The TUBB c.1201G>A variant is classified as a PATHOGENIC variant (PS2, PS3, PS4_moderate, PM2, PP3). The TUBB c.1201G>A variant is a single nucleotide change in exon 4/4 of the TUBB gene, which is predicted to change the amino acid glutamic acid at position 401 in the protein to lysine. The variant is in dbSNP (rs587777357) but is absent from population databases (PM2). Additionally, the variant has been previously detected in multiple unrelated individuals with clinical features of microcephaly and neurodevelopmental disease (PMID: 23246003, 30738969, 35183200) (PS4_moderate). Functional studies have demonstrated that this variant disrupted the morphology of cortical neurons, resulting in defects in synaptic signaling and the polymerization rates of the microtuble cytoskeleton (PMID: 23246003, 24833723) (PS3). The patient is de novo for this variant (PS2). The variant has been reported in ClinVar (Variation ID: 127191) or HGMD (Accession no.: CM1212023) as Pathogenic/ disease causing. Computational prediction support a deleterious effect on the gene or gene product (PP3). Clinical review is recommended. -
Inborn genetic diseases Pathogenic:1
- -
not provided Pathogenic:1
Published functional studies demonstrate a damaging effect (PMID: 23246003, 24833723); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23246003, 24833723, 35183220, 30738969) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at